Public trial registry of the CCC-Munich

Trial EMN17/54767414MMY3014 - The Perseus Trial

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
EMN17/54767414MMY3014 - The Perseus Trial
World
Full title
:

A Phase 3 Study Comparing Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) vs VELCADE, Lenalidomide, and Dexamethasone (VRd) in Subjects with Previously Untreated Multiple Myeloma who are Eligible for High-dose Therapy

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Chemo,Zielgerichtet - Therapieart: adjuvant

Participants
Function Prename Surname Organization
World Responsible contact Florian Bassermann 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier